Literature DB >> 21458183

Perfusion Computed Tomography (PCT) adopting different perfusion metrics: recurrence of brain metastasis or radiation necrosis?

Antonello Vidiri1, Antonino Guerrisi, Valentina Pinzi, Alessandra Fabi, Maria Alessandra Mirri, Alfredo Pompili, Nicoletta Caporale, Andrea Pace, Marcello Crecco, Simona Marzi.   

Abstract

OBJECTIVE: Different perfusion metrics were investigated to determine the accuracy of Perfusion CT (PCT) in differentiating recurrence of brain metastases from radiation necrosis in patients who previously underwent stereotactic radiation therapy (SRT). PATIENTS AND METHODS: Twenty patients previously treated with SRT underwent PCT examination of the brain. Normalized Cerebral Blood Volume (nCBV) values within the region of interest (ROI) were calculated. Fractional volumes at nCBV values between 1.0 and 2.25, defined as V(1.0)-V(2.25), were derived as alternative metrics and compared to the conventional method based on the mean CBV value within the lesion (nCBV(mean)). The Mann-Whitney test was used to compare the two patient's groups with recurrence and radiation necrosis with respect to the different nCBV metrics. Predictive powers and optimal thresholds for both the nCBV(mean) and the V(1.0)-V(2.25) were evaluated using the Receiver Operating Characteristic Curves. The gold standard was represented either by the histopathological examination or the Magnetic Resonance (MR) imaging follow-up longer than six months. RESULTS AND
CONCLUSION: The differences between the patient's group with recurrence and that with radiation necrosis resulted statistically significant for all the metrics, showing the lowest p-value for V(1.75) and V(2). The metrics based on the fractional volumes were found to show higher predictive powers, with the highest value of 0.96 for V(2.0). Quantitative analysis of the CBV map deriving different metrics may potentially improve the diagnostic accuracy of PCT in differentiating brain metastasis recurrence from radiation necrosis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21458183     DOI: 10.1016/j.ejrad.2011.02.068

Source DB:  PubMed          Journal:  Eur J Radiol        ISSN: 0720-048X            Impact factor:   3.528


  3 in total

Review 1.  Defining the endpoints: how to measure the efficacy of drugs that are active against central nervous system metastases.

Authors:  Alessandra Fabi; Antonello Vidiri
Journal:  Transl Lung Cancer Res       Date:  2016-12

2.  Survival prediction in high-grade gliomas using CT perfusion imaging.

Authors:  Timothy Pok Chi Yeung; Yong Wang; Wenqing He; Benedetta Urbini; Roberta Gafà; Linda Ulazzi; Slav Yartsev; Glenn Bauman; Ting-Yim Lee; Enrico Fainardi
Journal:  J Neurooncol       Date:  2015-04-11       Impact factor: 4.130

3.  Radionecrosis induced by stereotactic radiosurgery of brain metastases: results of surgery and outcome of disease.

Authors:  Stefano Telera; Alessandra Fabi; Andrea Pace; Antonello Vidiri; Vincenzo Anelli; Carmine Maria Carapella; Laura Marucci; Francesco Crispo; Isabella Sperduti; Alfredo Pompili
Journal:  J Neurooncol       Date:  2013-03-25       Impact factor: 4.130

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.